SCHEMBL17599453

SCHEMBL17599453

CCOC(=O)C1=C(c2ccc(NS(=O)(=O)c3c(C)c(C)cc(C)c3C)c3ccccc23)CCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 6/20 0.46
▸ NFE2L2 Q16236 3/20 0.46
▸ KMT2A Q03164 4/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ CRHBP P24387 1/20 0.44
▸ CRHR2 Q13324 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ LMNA P02545 4/20 0.40
▸ MAPT P10636 3/20 0.40
▸ CNR2 P34972 2/20 0.39
▸ TP53 P04637 2/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ THRB P10828 2/20 0.38
▸ SQSTM1 Q13501 1/20 0.38
▸ FNTA P49354 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599499 0.89 KEAP1 (0.48) KEAP1NFE2L2KMT2AMEN1KDM4E
SCHEMBL17599551 0.85 SLC6A2 (0.43) KEAP1NFE2L2KMT2AMEN1KDM4E
SCHEMBL17599346 0.79 CDC25B (0.45) KEAP1NFE2L2KMT2AMEN1KDM4E
SCHEMBL17599527 0.74 SLC6A3 (0.53) KEAP1NFE2L2KMT2AMEN1KDM4E
SCHEMBL17612852 0.72 KEAP1 (0.71) KEAP1NFE2L2KMT2AMEN1KDM4E
SCHEMBL17612859 0.72 KEAP1 (0.71) KEAP1NFE2L2KMT2AMEN1KDM4E
SCHEMBL17599447 0.72 KEAP1 (0.71) KEAP1NFE2L2KMT2AMEN1KDM4E
SCHEMBL17599324 0.69 MEN1 (0.47) KEAP1NFE2L2KMT2AMEN1KDM4E
SCHEMBL17599329 0.69 KMT2A (0.55) KEAP1NFE2L2KMT2AMEN1KDM4E
SCHEMBL17599363 0.69 MEN1 (0.53) KEAP1NFE2L2KMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997966-A1 Naphthyl Sulfonamide Pyrrolidine Derivatives as KEAP-1 Modulators for the Treatment of Diabetes, Obesity, Dyslipidemia and Related Disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2997966-A1 Naphthyl Sulfonamide Pyrrolidine Derivatives as KEAP-1 Modulators for the Treatment of Diabetes, Obesity, Dyslipidemia and Related Disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback